{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T12:52:53Z","timestamp":1753275173234},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.critrevonc.2015.03.007","type":"journal-article","created":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T19:07:31Z","timestamp":1428779251000},"page":"297-305","source":"Crossref","is-referenced-by-count":9,"title":["Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results"],"prefix":"10.1016","volume":"95","author":[{"given":"Franco","family":"Roviello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giandomenico","family":"Roviello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Petrioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Marrelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2015.03.007_bib0240","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00432-009-0667-4","article-title":"Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results","volume":"135","author":"Chua","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.critrevonc.2015.03.007_bib0245","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1470-2045(04)01425-1","article-title":"Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia","volume":"5","author":"Glehen","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.critrevonc.2015.03.007_bib0250","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/(SICI)1098-2388(199804\/05)14:3<254::AID-SSU10>3.0.CO;2-U","article-title":"Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis","volume":"14","author":"Sugarbaker","year":"1998","journal-title":"Semin Surg Oncol"},{"key":"10.1016\/j.critrevonc.2015.03.007_bib0255","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/PPO.0b013e3181a58d95","article-title":"Pharmacokinetics and pharmacodynamics of perioperative cancer chemotherapy in peritoneal surface malignancy","volume":"15","author":"Van der Speeten","year":"2009","journal-title":"Cancer J"},{"key":"10.1016\/j.critrevonc.2015.03.007_bib0260","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"key":"10.1016\/j.critrevonc.2015.03.007_bib0265","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1093\/annonc\/mdm137","article-title":"Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer","volume":"18","author":"Bijelic","year":"2007","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.critrevonc.2015.03.007_bib0270","first-page":"78","article-title":"Intraperitoneal hyperthermic chemotherapy for advanced gastrointestinal and ovarian cancers","volume":"7","author":"Loggie","year":"1995","journal-title":"Reg Cancer Treat"},{"issue":"7","key":"10.1016\/j.critrevonc.2015.03.007_bib0275","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1634\/theoncologist.2008-0275","article-title":"The role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer","volume":"14","author":"Helm","year":"2009","journal-title":"Oncologist"},{"issue":"June (5)","key":"10.1016\/j.critrevonc.2015.03.007_bib0280","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/IGC.0b013e31824d836c","article-title":"Evaluation of extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced epithelial ovarian cancer","volume":"22","author":"Ansaloni","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"12","key":"10.1016\/j.critrevonc.2015.03.007_bib0285","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.ejso.2013.09.030","article-title":"Peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients","volume":"39","author":"Bakrin","year":"2013","journal-title":"Eur J Surg Oncol"},{"issue":"July (7)","key":"10.1016\/j.critrevonc.2015.03.007_bib0290","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1245\/s10434-014-3599-4","article-title":"Treatment of microscopic disease with hyperthermic intraoperative intraperitoneal chemotherapy after complete cytoreduction improves disease-free survival in patients with stage IIIC\/IV ovarian cancer","volume":"21","author":"Cascales-Campos","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.critrevonc.2015.03.007_bib0295","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ygyno.2011.05.004","article-title":"Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy as up front therapy for advanced, EOC: multi-institutional phase II study","volume":"122","author":"Deraco","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2015.03.007_bib0300","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/cncr.23553","article-title":"Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer","volume":"113","author":"Di Giorgio","year":"2008","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2015.03.007_bib0305","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/IGC.0b013e3181c50cde","article-title":"HIPEC in ovarian cancer: first report of HYPER-O registry","volume":"20","author":"Helm","year":"2010","journal-title":"Int J Gynecol Cancer"},{"issue":"November (11)","key":"10.1016\/j.critrevonc.2015.03.007_bib0310","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.ejso.2009.03.004","article-title":"Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer \u2013 12-year single center experience","volume":"35","author":"Pavlov","year":"2009","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.critrevonc.2015.03.007_bib0315","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/jso.20597","article-title":"Radical surgery\u2014peritonectomy and intra-operative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer","volume":"94","author":"Rufian","year":"2006","journal-title":"J Surg Oncol"},{"issue":"January (1)","key":"10.1016\/j.critrevonc.2015.03.007_bib0320","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/jso.21732","article-title":"Oxaliplatin-based hyperthermic intraperitoneal chemotherapy in primary or recurrent epithelial ovarian cancer: a pilot study of 31 patients","volume":"103","author":"Frenel","year":"2011","journal-title":"J Surg Oncol"},{"issue":"March\u2013April (2)","key":"10.1016\/j.critrevonc.2015.03.007_bib0325","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1525-1438.2005.15209.x","article-title":"Intraperitoneal hyperthermic chemotherapy in ovarian cancer","volume":"15","author":"Gori","year":"2005","journal-title":"Gynecol Cancer"},{"issue":"February (2)","key":"10.1016\/j.critrevonc.2015.03.007_bib0330","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jso.21448","article-title":"Consolidation hyperthermic intraperitoneal chemotherapy using paclitaxel in patients with epithelial ovarian cancer","volume":"101","author":"Kim","year":"2010","journal-title":"J Surg Oncol"},{"issue":"June (6)","key":"10.1016\/j.critrevonc.2015.03.007_bib0335","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ejso.2010.04.005","article-title":"Hyperthermic intra-peritoneal chemotherapy using oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma: results of a phase II prospective multicentre trial. CHIPOVAC study","volume":"36","author":"Pomel","year":"2010","journal-title":"Eur J Surg Oncol"},{"issue":"November (6)","key":"10.1016\/j.critrevonc.2015.03.007_bib0340","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/jso.21682","article-title":"Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer","volume":"102","author":"Roviello","year":"2010","journal-title":"J Surg Oncol"},{"issue":"September","key":"10.1016\/j.critrevonc.2015.03.007_bib0345","article-title":"The role of hyperthermic intraperitoneal chemotherapy using paclitaxel in platinum-sensitive recurrent epithelial ovarian cancer patients with microscopic residual disease after cytoreduction","author":"Cascales-Campos","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"July (7)","key":"10.1016\/j.critrevonc.2015.03.007_bib0350","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1245\/s10434-009-0878-6","article-title":"Cytoreduction and hyperthermic intraperitoneal chemoperfusion in women with heavily pretreated recurrent ovarian cancer","volume":"19","author":"Ceelen","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.critrevonc.2015.03.007_bib0355","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s00268-007-9146-8","article-title":"Cytoreductive surgery and intraperitoneal chemo-hyperthermia for chemoresistant and recurrent advanced epithelial ovarian cancer: prospective study of 81 patients","volume":"31","author":"Cotte","year":"2007","journal-title":"World J Surg"},{"issue":"June (7)","key":"10.1016\/j.critrevonc.2015.03.007_bib0360","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1471-0528.2011.03207.x","article-title":"Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer: a multi-institutional study","volume":"119","author":"Deraco","year":"2012","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.critrevonc.2015.03.007_bib0365","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ygyno.2011.04.008","article-title":"HIPEC in recurrent ovarian cancer patients: morbidity-related treatment and long-term analysis of clinical outcome","volume":"122","author":"Fagotti","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"December (3)","key":"10.1016\/j.critrevonc.2015.03.007_bib0370","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ygyno.2012.09.020","article-title":"Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: a case\u2013control study on survival in patients with two year follow-up","volume":"127","author":"Fagotti","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"October (7)","key":"10.1016\/j.critrevonc.2015.03.007_bib0375","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00423-011-0835-2","article-title":"Cytoreductive surgery and HIPEC in peritoneal recurrent ovarian cancer: experience and lessons learned","volume":"396","author":"K\u00f6nigsrainer","year":"2011","journal-title":"Langenbecks Arch Surg"},{"issue":"October (11)","key":"10.1016\/j.critrevonc.2015.03.007_bib0380","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1245\/s10434-014-3693-7","article-title":"Survival benefit of hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer: a multi-institutional case control study","volume":"21","author":"Le Brun","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.critrevonc.2015.03.007_bib0385","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ejso.2006.03.011","article-title":"Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced\/recurrent ovarian cancer patients: the experience of National Cancer Institute of Milan","volume":"32","author":"Raspagliesi","year":"2006","journal-title":"Eur J Surg Oncol"},{"issue":"February (1)","key":"10.1016\/j.critrevonc.2015.03.007_bib0390","first-page":"27","article-title":"Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"69","author":"Robella","year":"2014","journal-title":"Minerva Chir"},{"issue":"1","key":"10.1016\/j.critrevonc.2015.03.007_bib0395","first-page":"74","article-title":"The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of recurrent advanced ovarian cancer: a prospective study","volume":"16","author":"Spiliotis","year":"2011","journal-title":"J BUON"},{"issue":"October (10)","key":"10.1016\/j.critrevonc.2015.03.007_bib0400","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s00268-004-7461-x","article-title":"Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer","volume":"28","author":"Zanon","year":"2004","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.critrevonc.2015.03.007_bib0405","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ygyno.2007.03.019","article-title":"Treatment of ovarian cancer with paclitaxel- or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgery","volume":"106","author":"Bae","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2015.03.007_bib0410","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ygyno.2004.05.044","article-title":"Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer","volume":"94","author":"Ryu","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"April (4)","key":"10.1016\/j.critrevonc.2015.03.007_bib0415","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1245\/s10434-008-0299-y","article-title":"Hyperthermic intraperitoneal chemotherapy after extensive cytoreductive surgery in patients with primary advanced epithelial ovarian cancer: interim analysis of a phase II study","volume":"16","author":"Lim","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"January (1)","key":"10.1016\/j.critrevonc.2015.03.007_bib0420","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2008.08.033","article-title":"Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis","volume":"112","author":"Bristow","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"February (2)","key":"10.1016\/j.critrevonc.2015.03.007_bib0425","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ygyno.2013.12.028","article-title":"Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: a case series","volume":"132","author":"Fagotti","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"October (10)","key":"10.1016\/j.critrevonc.2015.03.007_bib0430","first-page":"5689","article-title":"Short-term outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: preliminary analysis of a multicentre study","volume":"34","author":"Macr\u00ec","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.critrevonc.2015.03.007_bib0435","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/SLA.0b013e3181a45d86","article-title":"Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality","volume":"249","author":"Chua","year":"2009","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.critrevonc.2015.03.007_bib0440","first-page":"259","article-title":"Morbidity and mortality of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal carcinomatosis","volume":"14","author":"Spiliotis","year":"2009","journal-title":"J BUON"},{"issue":"November","key":"10.1016\/j.critrevonc.2015.03.007_bib0445","article-title":"Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study","author":"Spiliotis","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.critrevonc.2015.03.007_bib0450","unstructured":"www.clinicaltrials.gov\/ct2\/show\/record\/NCT00426257."},{"key":"10.1016\/j.critrevonc.2015.03.007_bib0455","unstructured":"www.clinicaltrials.gov\/ct2\/show\/record\/NCT01376752."},{"key":"10.1016\/j.critrevonc.2015.03.007_bib0460","unstructured":"www.clinicaltrials.gov\/ct2\/show\/record\/NCT01539785."},{"key":"10.1016\/j.critrevonc.2015.03.007_bib0465","unstructured":"www.clinicaltrials.gov\/ct2\/show\/record\/NCT01628380."},{"issue":"July (3)","key":"10.1016\/j.critrevonc.2015.03.007_bib0470","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S1055-3207(03)00027-9","article-title":"Management of peritoneal surface component of ovarian cancer","volume":"12","author":"Deraco","year":"2003","journal-title":"Surg Oncol Clin N Am"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842815000633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842815000633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T19:59:45Z","timestamp":1598903985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842815000633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1040842815000633"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2015.03.007","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}